These pathological findings are similar to those of human Parkinson’s disease, and very interestingly, genetic depletion of alpha-synuclein with the CRISPR–Cas9 system mitigates neurodegeneration (Matsui et al., 2019). This evidence concerns the gene SNCA and Parkinson disease.